Haensler Jean
Sanofi Pasteur, Marcy l'Etoile, France.
Methods Mol Biol. 2010;626:73-90. doi: 10.1007/978-1-60761-585-9_6.
Many preclinical and clinical results indicate that liposomal systems can serve as effective adjuvants to subunit vaccines by enabling the formulation and delivery of vaccine antigens and immunopotentiators. The adjuvant effect of liposomes usually depends on both the composition of the lipid vesicles and their physical association with the vaccine antigen. This chapter describes methods for the preparation and characterization of sterile small, mostly unilamellar, lipid vesicles and for their association with vaccine antigens. It gives also some recommendations for the optimization of liposomal vaccines in preclinical testing. The most common immunopotentiators used in liposomal adjuvants are also described.
许多临床前和临床研究结果表明,脂质体系统能够通过实现疫苗抗原和免疫增强剂的配制与递送,作为亚单位疫苗的有效佐剂。脂质体的佐剂效应通常取决于脂质囊泡的组成及其与疫苗抗原的物理结合。本章介绍了无菌的、大多为单层的小脂质囊泡的制备和表征方法,以及它们与疫苗抗原结合的方法。本章还给出了一些在临床前试验中优化脂质体疫苗的建议。文中还介绍了脂质体佐剂中最常用的免疫增强剂。